Huntsville, Ala. – Brittany Lasseigne, PhD, a senior scientist at HudsonAlpha Institute for Biotechnology, has been selected by the National Institutes of Health (NIH) to receive a Pathway to Independence (K99) training grant. The NIH established the Pathway to Independence award to increase and maintain a strong cohort of new independent investigators.
Brittany Lasseigne, PhD
Over the next year, Lasseigne will continue and expand her research into developing novel strategies to use computational genomics to study complex human diseases. Lasseigne, who already is an accomplished and published investigator, will undergo a formal mentoring and training program in genomics, computer science, statistics and career development under the leadership of Rick Myers, PhD, president and science director of HudsonAlpha. She also will work with Greg Cooper, PhD, faculty investigator at HudsonAlpha.
“By using machine learning and novel data integration approaches, I will leverage the unique information captured by different genomic sequencing technologies to help improve big data integration and also to generate genomic signatures for cancers and psychiatric diseases,” Lasseigne explained. “My goal is to better understand the relationships between the different types of genomic data, which will lead to better tools for future genomic research, improve understanding of the basic mechanisms of molecular processes, and establish clinical utility of molecular changes associated with disease.”
The one-year training program is followed by a three-year structured independent research program.
Research reported in this article is supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number K99HG009678. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to developing and applying scientific advances to health, agriculture, learning, and commercialization. Opened in 2008, HudsonAlpha’s vision is to leverage the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. The state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education and includes more than 30 diverse biotech companies on campus. To learn more about HudsonAlpha, visit hudsonalpha.org.
Media Contact:
Margetta Thomas
mthomas@hudsonalpha.org
256-327-0425
